Johnson & Johnson

Johnson & Johnson is a multinational healthcare and pharmaceutical conglomerate that appears across elsewhere's coverage primarily as an employer of talent moving into Chinese startups and as a partner in drug development. The bundle shows its consumer-facing side through former executives like Tang Liang, who led marketing for Johnson's baby and other brands before founding the plant-based hair-care brand 植观 in 2015 . Its pharmaceutical arm, Janssen, engages in research collaborations with Chinese biotech firms — for instance, a 2022 deal with XtalPi for AI-driven small-molecule design, and a partnership with Mirxes in pulmonary hypertension using miRNA technology . In the radiopharma sector, Johnson & Johnson is among the large multinational drugmakers acquiring or partnering to build nuclear medicine pipelines, alongside Novartis, BMS, Eli Lilly and AstraZeneca . The company also historically employed Chen Kan, now at Qiming Venture Partners, as a senior scientist in oncology drug R&D .